Influence of Chronic Fatigue Syndrome Codiagnosis on the Relationship between Perceived and Objective Psychoneuro-Immunoendocrine Disorders in Women with Fibromyalgia
暂无分享,去创建一个
[1] M. D. Hinchado,et al. Synbiotic Supplementation Improves Quality of Life and Inmunoneuroendocrine Response in Patients with Fibromyalgia: Influence of Codiagnosis with Chronic Fatigue Syndrome , 2023, Nutrients.
[2] L. Martín-Cordero,et al. Influence of Codiagnosis of Chronic Fatigue Syndrome and Habitual Physical Exercise on the Psychological Status and Quality of Life of Patients with Fibromyalgia , 2022, Journal of clinical medicine.
[3] T. Caycho-Rodríguez,et al. Measurement of coronaphobia in older adults: Validation of the Spanish version of the Coronavirus Anxiety Scale , 2021, Revista Española de Geriatría y Gerontología.
[4] Lindsay P Toth,et al. Time Trends in Physical Activity Using Wearable Devices: A Systematic Review and Meta-analysis of Studies from 1995 to 2017 , 2021, Medicine and science in sports and exercise.
[5] M. Robles-Bello,et al. The COVID-19 Fear Scale (FCV-19S): Psychometric properties and invariance of the measure in the Spanish version. , 2021, Actas espanolas de psiquiatria.
[6] R. Smeets,et al. An exploratory study of discrepancies between objective and subjective measurement of the physical activity level in female patients with chronic fatigue syndrome. , 2021, Journal of psychosomatic research.
[7] Sherman A. Lee. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety , 2020, Death studies.
[8] M. Neumeister,et al. Fibromyalgia. , 2020, Clinics in plastic surgery.
[9] A. Pakpour,et al. The Fear of COVID-19 Scale: Development and Initial Validation , 2020, International Journal of Mental Health and Addiction.
[10] M. Koutsilieris,et al. The effect of treatment regimens on salivary cortisol levels in patients with chronic musculoskeletal disorders. , 2020, Journal of bodywork and movement therapies.
[11] B. Lidbury,et al. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Comprehensive Review , 2019, Diagnostics.
[12] Serge Marchand,et al. Impact of a specific training programme on the neuromodulation of pain in female patient with fibromyalgia (DouFiSport): a 24-month, controlled, randomised, double-blind protocol , 2019, BMJ Open.
[13] F. Molina,et al. Catecholamine and Indolamine Pathway: A Case–Control Study in Fibromyalgia , 2018, Biological research for nursing.
[14] U. Nater,et al. Hair and salivary cortisol in a cohort of women with chronic fatigue syndrome , 2018, Hormones and Behavior.
[15] N. Üçeyler,et al. Serotonin and noradrenaline reuptake inhibitors (SNRIs) for fibromyalgia , 2018, The Cochrane database of systematic reviews.
[16] G. Buela-Casal,et al. Short form of the Spanish adaptation of the State-Trait Anxiety Inventory , 2017, International journal of clinical and health psychology : IJCHP.
[17] A. Marques,et al. Prevalence of fibromyalgia: literature review update. , 2017, Revista brasileira de reumatologia.
[18] R. Geenen,et al. The discordance between subjectively and objectively measured physical function in women with fibromyalgia: association with catastrophizing and self-efficacy cognitions. The al-Ándalus project , 2016, Disability and rehabilitation.
[19] Philip J Mease,et al. 2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteria. , 2016, Seminars in arthritis and rheumatism.
[20] E. Ortega. The “bioregulatory effect of exercise” on the innate/inflammatory responses , 2016, Journal of Physiology and Biochemistry.
[21] M. Fletcher,et al. Illness progression in chronic fatigue syndrome: a shifting immune baseline , 2016, BMC Immunology.
[22] N. Pattyn,et al. Associations Between Cognitive Performance and Pain in Chronic Fatigue Syndrome: Comorbidity with Fibromyalgia Does Matter. , 2015, Pain physician.
[23] C. Vázquez,et al. Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): 2. Propiedades psicométricas en población general The spanish adaptation of Beck's Depression Inventory-II (BDI-II): 2. Psychometric properties in the general population , 2015 .
[24] S. Mackey,et al. Proinflammatory cytokines and DHEA-S in women with fibromyalgia: impact of psychological distress and menopausal status , 2014, Journal of pain research.
[25] E. Ortega,et al. Soluble fractalkine in the plasma of fibromyalgia patients. , 2014, Anais da Academia Brasileira de Ciencias.
[26] G. Chrousos,et al. The Healthy Lifestyle and Personal Control Questionnaire (HLPCQ): a novel tool for assessing self-empowerment through a constellation of daily activities , 2014, BMC Public Health.
[27] J. García,et al. Altered profile of chemokines in fibromyalgia patients , 2014, Annals of clinical biochemistry.
[28] M. D. Hinchado,et al. An exploratory study of the effect of regular aquatic exercise on the function of neutrophils from women with fibromyalgia: Role of IL-8 and noradrenaline , 2014, Brain, Behavior, and Immunity.
[29] R. Moss‐Morris,et al. Unstimulated cortisol secretory activity in everyday life and its relationship with fatigue and chronic fatigue syndrome: A systematic review and subset meta-analysis , 2013, Psychoneuroendocrinology.
[30] M. D. Hinchado,et al. Fibromyalgia: Anti-Inflammatory and Stress Responses after Acute Moderate Exercise , 2013, PloS one.
[31] P. Wiffen. SEROTONIN AND NORADRENALINE REUPTAKE INHIBITORS (SNRIs) FOR FIBROMYALGIA SYNDROME , 2013 .
[32] G. Cardon,et al. Actigraph GT3X: Validation and Determination of Physical Activity Intensity Cut Points , 2013, International Journal of Sports Medicine.
[33] Gordon Broderick,et al. Biomarkers for chronic fatigue , 2012, Brain, Behavior, and Immunity.
[34] J. García,et al. Inflammatory/Stress Feedback Dysregulation in Women with Fibromyalgia , 2012, Neuroimmunomodulation.
[35] Charles D. Spielberger,et al. State-Trait Anxiety Inventory for Adults , 2012 .
[36] E. Giraldo,et al. Aquatic exercise improves the monocyte pro‐ and anti‐inflammatory cytokine production balance in fibromyalgia patients , 2012, Scandinavian journal of medicine & science in sports.
[37] M. Yunus. The Prevalence of Fibromyalgia in Other Chronic Pain Conditions , 2011, Pain research and treatment.
[38] D. Cook,et al. Are women with fibromyalgia less physically active than healthy women? , 2011, Medicine and science in sports and exercise.
[39] P. Kellam,et al. Assessment of a 44 Gene Classifier for the Evaluation of Chronic Fatigue Syndrome from Peripheral Blood Mononuclear Cell Gene Expression , 2011, PloS one.
[40] L. D. Robredo,et al. Estabilidad emocional y cortisol como factores diferenciadores de la fibromialgia , 2011 .
[41] K. Mannerkorpi,et al. Transcultural adaptation and psychometric properties of a Spanish-language version of physical activity instruments for patients with fibromyalgia. , 2011, Archives of physical medicine and rehabilitation.
[42] F. Salaffi,et al. Pharmacological treatment of fibromyalgia. , 2010, Clinical and experimental rheumatology.
[43] S. Wessely,et al. Does hypocortisolism predict a poor response to cognitive behavioural therapy in chronic fatigue syndrome? , 2009, Psychological Medicine.
[44] D. Buskila,et al. Pathogenesis of fibromyalgia - a review. , 2008, Joint, bone, spine : revue du rhumatisme.
[45] Paul Kellam,et al. Gene expression subtypes in patients with chronic fatigue syndrome/myalgic encephalomyelitis. , 2008, The Journal of infectious diseases.
[46] H. Besedovsky,et al. Physiology of psychoneuroimmunology: A personal view , 2007, Brain, Behavior, and Immunity.
[47] E. Remor,et al. Psychometric Properties of a European Spanish Version of the Perceived Stress Scale (PSS) , 2006, The Spanish Journal of Psychology.
[48] J. Rivera,et al. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. , 2004, Clinical and experimental rheumatology.
[49] K. Nas,et al. Cortisol and hypothalamic–pituitary–gonadal axis hormones in follicular-phase women with fibromyalgia and chronic fatigue syndrome and effect of depressive symptoms on these hormones , 2004, Arthritis research & therapy.
[50] D. Buchwald,et al. Chronic diffuse musculoskeletal pain, fibromyalgia and co-morbid unexplained clinical conditions. , 2003, Best practice & research. Clinical rheumatology.
[51] R. Shephard. Limits to the measurement of habitual physical activity by questionnaires , 2003, British journal of sports medicine.
[52] C. Cleeland,et al. Validación española del cuestionario Brief Pain Inventory en pacientes con dolor de causa neoplásica , 2003 .
[53] T. Pollmächer,et al. The endotoxin-induced increase of cytokines is followed by an increase of cortisol relative to dehydroepiandrosterone (DHEA) in healthy male subjects. , 2002, The Journal of endocrinology.
[54] G. Chrousos,et al. Stress Hormones, Proinflammatory and Antiinflammatory Cytokines, and Autoimmunity , 2002, Annals of the New York Academy of Sciences.
[55] D. Papanicolaou,et al. Responses of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis to interleukin-6: a pilot study in fibromyalgia. , 2000, Arthritis and rheumatism.
[56] P. Keck,et al. Antidepressant treatment of fibromyalgia. A meta-analysis and review. , 2000, Psychosomatics.
[57] C. Cleeland,et al. The rapid assessment of fatigue severity in cancer patients , 1999, Cancer.
[58] M. Mikkelsson. One year outcome of preadolescents with fibromyalgia. , 1999, The Journal of rheumatology.
[59] P S Freedson,et al. Calibration of the Computer Science and Applications, Inc. accelerometer. , 1998, Medicine and science in sports and exercise.
[60] R. Daynes,et al. Dysregulation of IL-10 production with aging: Possible linkage to the age-associated decline in DHEA and its sulfated derivative , 1996, Experimental Gerontology.
[61] Ian Hickie,et al. The Chronic Fatigue Syndrome: A Comprehensive Approach to Its Definition and Study , 1994, Annals of Internal Medicine.
[62] S. Pillemer,et al. Hypothalamic-pituitary-adrenal axis perturbations in patients with fibromyalgia. , 1994, Arthritis and rheumatism.
[63] D. Buchwald,et al. Comparison of patients with chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities. , 1994, Archives of internal medicine.
[64] R M Bennett,et al. The fibromyalgia impact questionnaire: development and validation. , 1991, The Journal of rheumatology.
[65] A. Komaroff,et al. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. , 1990, Arthritis and rheumatism.
[66] T. Kamarck,et al. A global measure of perceived stress. , 1983, Journal of health and social behavior.
[67] C. Cleeland,et al. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.
[68] A. Beck,et al. An inventory for measuring depression. , 1961, Archives of general psychiatry.
[69] A. Marques,et al. Prevalence of fibromyalgia: literature review update. , 2017, Revista brasileira de reumatologia.
[70] Julián Pérez-Villacastín,et al. [Evolution and scientific impact of research grants from the spanish society of cardiology and spanish heart foundation (2000-2006)]. , 2011, Revista espanola de cardiologia.
[71] F. Félix-Redondo,et al. [Prevalence, awareness, treatment and control of cardiovascular risk factors in the Extremadura population (Spain). HERMEX study]. , 2011, Atencion primaria.
[72] H. Northoff,et al. Exercise in fibromyalgia and related inflammatory disorders: known effects and unknown chances. , 2009, Exercise immunology review.
[73] I. Russell,et al. Platelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome. , 1992, The Journal of rheumatology.
[74] G. A. Mccain,et al. Diurnal hormone variation in fibromyalgia syndrome: a comparison with rheumatoid arthritis. , 1989, The Journal of rheumatology. Supplement.